Beth Gaspich - NICE Chief Officer
| NCSYF Stock | USD 169.00 5.06 2.91% |
Executive
Ms. Beth Gaspich serves as Chief Financial Officer at Nice Ltd since October 10, 2016. Her work experience includes the following roles Chief Financial Officer at NiceActimize, Chief Financial Officer at Archive Systems, Inc, Founding Member of RiskMetrics Group, Inc, Vice PresidentFinance at RiskMetrics Group, Inc and has held several other senior positions throughout her career at large global financial institutions, including JP Morgan and Price Waterhouse. She holds a Bachelors degree in Accounting from University of MissouriKansas City. since 2016.
| Age | 57 |
| Tenure | 8 years |
| Phone | 972 9 775 3151 |
| Web | https://www.nice.com |
NICE Management Efficiency
The company has return on total asset (ROA) of 0.0433 % which means that it generated a profit of $0.0433 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0863 %, meaning that it generated $0.0863 on every $100 dollars invested by stockholders. NICE's management efficiency ratios could be used to measure how well NICE manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Jeremy King | 55 | ||
| Doniel Sutton | 50 | ||
| Tse Yang | 47 | ||
| Brian JD | Merit Medical Systems | 63 | |
| Wen Li | Weibo Corp | N/A | |
| Bill Watkins | N/A | ||
| Sarah Comstock | Merit Medical Systems | N/A | |
| Sabrina Ellis | 51 | ||
| Zenghui Cao | Weibo Corp | 46 | |
| DeAnna Osteen | Weyco Group | N/A | |
| Jeff Douglass | Weyco Group | 42 | |
| Malik Ducard | 51 | ||
| Yun Lee | Franklin Wireless Corp | 63 | |
| Julia Donnelly | 41 | ||
| Alisha Jerauld | Merit Medical Systems | N/A | |
| Brian Lloyd | Merit Medical Systems | 63 | |
| Mark Butler | Merit Medical Systems | N/A | |
| JoAnne Alkire | Merit Medical Systems | N/A | |
| Wanjiku JD | 53 | ||
| Wanjiku Walcott | 53 | ||
| Christine Flores | 45 | ||
Management Performance
| Return On Equity | 0.0863 | |||
| Return On Asset | 0.0433 |
NICE Leadership Team
Elected by the shareholders, the NICE's board of directors comprises two types of representatives: NICE inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NICE. The board's role is to monitor NICE's management team and ensure that shareholders' interests are well served. NICE's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NICE's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shiri Neder, Ex HR | ||
| Beth Gaspich, Chief Officer | ||
| Yaron Hertz, President-NICE Americas | ||
| John OHara, President-NICE EMEA | ||
| Craig Costigan, Chief Actimize | ||
| Barak Eilam, Chief Officer | ||
| Tali MirskyLachman, Vice President General Counsel, Secretary | ||
| Paul Jarman, CEO of inContact | ||
| Barry Cooper, Pres Division | ||
| Christopher Wooten, Executive Vice President-Vertical Markets |
NICE Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is NICE a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0863 | |||
| Return On Asset | 0.0433 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 11.93 B | |||
| Shares Outstanding | 63.53 M | |||
| Shares Owned By Institutions | 12.10 % | |||
| Price To Earning | 67.11 X | |||
| Price To Book | 4.45 X | |||
| Price To Sales | 5.97 X |
Currently Active Assets on Macroaxis
Other Information on Investing in NICE Pink Sheet
NICE financial ratios help investors to determine whether NICE Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NICE with respect to the benefits of owning NICE security.